Potential therapeutic approach of intravenous immunoglobulin against COVID-19

Abstract

Abstract Since the outbreak of the novel coronavirus disease (COVID-19), the therapeutic and management options to reduce the burden of the COVID-19 disease are under investigation. IVIG therapy is used as an effective treatment for immunodeficient patients and patients with inflammatory or autoimmune conditions. The therapeutic effect of IVIG in COVID-19 patients has been investigated. But, the results are controversial and some studies reported no benefit of IVIG therapy. More clinical trials on the effect of IVIG therapy in COVID-19 patients should be performed to establish a certain conclusion about IVIG effectiveness.

Keywords

• Coronavirus disease
• Intravenous immunoglobulin
• Respiratory syndromes
• Hyperreactivity
• Treatment